Bone Marrow & Stem Cell Transplant

>

Latest News

Ponatinib, Chemo, and Transplant Shows Promise for Long-Term Survival in Ph+ ALL
Ponatinib, Chemo, and Transplant Shows Promise for Long-Term Survival in Ph+ ALL

June 20th 2024

The phase 2 PONALFIL trial evaluating a ponatinib regimen shows promise for long-term survival in adult patients with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia.

Long-Term Quality of Life Remains Positive for Transplant Patients, Regardless of Donor Match
Long-Term Quality of Life Remains Positive for Transplant Patients, Regardless of Donor Match

June 18th 2024

Iomab-B Leads to Durable Complete Remission in Phase 3 SIERRA Trial
Iomab-B Leads to Durable Complete Remission in Phase 3 SIERRA Trial

June 14th 2024

Recognizing cGVHD and When to Make Key Management Decisions
Recognizing cGVHD and When to Make Key Management Decisions

June 10th 2024

Exploring the Frailty Factor in Stem Cell Transplant Hospitalization
Exploring the Frailty Factor in Stem Cell Transplant Hospitalization

May 7th 2024

Video Series
Video Interviews

More News